Copenhagen University Hospital

At Copenhagen University Hospital, the Department of Neuroanaesthesiology is involved in research on nervous system diseases, with a focus on severe seizure emergencies such as refractory status epilepticus. These studies are designed to assess whether new treatments can improve seizure control, safety, and tolerability when standard care is not enough.

• Evaluating a new therapy added to standard anti-seizure treatment for refractory status epilepticus
• Studying better ways to manage life-threatening seizure activity in emergency care

The research reflects a strong interest in improving outcomes for patients with urgent neurologic conditions.

This site also supports clinical research in neoplasms, especially malignant pleural mesothelioma. The trials are exploring whether immune-based treatments can help patients whose disease has progressed after earlier chemotherapy, with the goal of improving treatment effectiveness in a difficult-to-treat cancer.

• Testing immunotherapy combinations for malignant pleural mesothelioma
• Exploring whether adding a vaccine approach may strengthen cancer control

These studies contribute to the broader search for better options in advanced respiratory tract-related cancers.

Clinical trials at Copenhagen University Hospital include work in nutritional and metabolic diseases, particularly obesity and related cardiovascular risk. The research aims to determine whether new treatments can support weight management while also improving long-term heart and vascular safety.

• Assessing a potential treatment for people with overweight or obesity
• Examining cardiovascular safety alongside metabolic benefit

These efforts highlight interest in therapies that address both body weight and broader metabolic health.

Research in congenital, hereditary, and neonatal diseases includes studies of congenital adrenal hyperplasia, a rare endocrine condition. The purpose of this work is to evaluate new treatment options that may better support disease control and improve quality of life for people living with this inherited disorder.

• Investigating a new therapy for congenital adrenal hyperplasia
• Advancing care for a rare inherited hormonal disorder

Across these trials, the site demonstrates a broad commitment to both rare disease research and clinically urgent conditions.